GlucoTrack Statistics
Total Valuation
GlucoTrack has a market cap or net worth of $1.57 million. The enterprise value is -$3.00 million.
Important Dates
The last earnings date was Thursday, November 13, 2025, after market close.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
GlucoTrack has 1.01 million shares outstanding.
| Current Share Class | 1.01M |
| Shares Outstanding | 1.01M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +81.88% |
| Owned by Insiders (%) | 0.64% |
| Owned by Institutions (%) | 1.40% |
| Float | 959,047 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.51 |
| P/TBV Ratio | 0.57 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.53, with a Debt / Equity ratio of 1.20.
| Current Ratio | 1.53 |
| Quick Ratio | 1.49 |
| Debt / Equity | 1.20 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -55.22 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -225.66% |
| Return on Invested Capital (ROIC) | -480.41% |
| Return on Capital Employed (ROCE) | -549.85% |
| Weighted Average Cost of Capital (WACC) | 6.75% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.35M |
| Employee Count | 11 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -96.81% in the last 52 weeks. The beta is 0.31, so GlucoTrack's price volatility has been lower than the market average.
| Beta (5Y) | 0.31 |
| 52-Week Price Change | -96.81% |
| 50-Day Moving Average | 4.28 |
| 200-Day Moving Average | 6.23 |
| Relative Strength Index (RSI) | 17.87 |
| Average Volume (20 Days) | 929,875 |
Short Selling Information
The latest short interest is 31,889, so 3.15% of the outstanding shares have been sold short.
| Short Interest | 31,889 |
| Short Previous Month | 44,499 |
| Short % of Shares Out | 3.15% |
| Short % of Float | 3.33% |
| Short Ratio (days to cover) | 1.03 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -16.46M |
| Pretax Income | -25.85M |
| Net Income | -25.85M |
| EBITDA | -16.38M |
| EBIT | -16.46M |
| Earnings Per Share (EPS) | -$65.45 |
Full Income StatementBalance Sheet
The company has $7.87 million in cash and $3.30 million in debt, with a net cash position of $4.57 million or $4.52 per share.
| Cash & Cash Equivalents | 7.87M |
| Total Debt | 3.30M |
| Net Cash | 4.57M |
| Net Cash Per Share | $4.52 |
| Equity (Book Value) | 2.75M |
| Book Value Per Share | 3.06 |
| Working Capital | 2.81M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$14.80 million and capital expenditures -$76,000, giving a free cash flow of -$14.88 million.
| Operating Cash Flow | -14.80M |
| Capital Expenditures | -76,000 |
| Free Cash Flow | -14.88M |
| FCF Per Share | -$14.71 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
